Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: Safety and Tolerability of Pirfenidone in Acute Pancreatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial is evaluating the safety and tolerability of pirfenidone in patients with acute pancreatitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Pancreatitis, Acute | Phase 1, Phase 2 | Status: RECRUITING